Ligand Pharmaceuticals, Inc.

NASDAQ: LGND
$92.08
-$2.07 (-2.2%)
Closing price September 18, 2020
Short sellers seem to have many emerging and speculative biotech stocks targeted for termination. Here are eight of them against which short sellers are betting the farm.
In a new research report, RBC did some intense digging in the small-cap arena and came up with some fascinating research. These are five top small-cap growth plays suited for aggressive accounts.
The top analyst upgrades, downgrades and initiations seen on Wednesday included Activision Blizzard, Biogen, Deere, DocuSign, Ford, Freeport-McMoRan, General Motors, Lattice Semiconductor, Qualys,...
Nordstrom, Tailored Brands, Electronics for Imaging and Ligand Pharmaceuticals had all posted new 52-week lows by noon Wednesday.
The top analyst upgrades, downgrades and other research calls from Monday included Amazon.com, Anheuser-Busch Inbev, Caterpillar, HUYA, Ligand Pharmaceuticals, Verizon and Weyerhaeuser.
The top analyst upgrades, downgrades and other research calls from Friday include DSW, Dean Foods, Fluor, JD.com, Nvidia, Viper Energy and Walmart.
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Barrick Gold, Caterpillar, ConocoPhillips, PNC Financial, Tonix Pharmaceuticals and Spirit Realty.
Insider selling is likely to keep ramping higher, as many on Wall Street see volatility going higher this summer as we get closer to the political cycle home stretch.
We mentioned often that the market has not seen a 10% correction for three years. This week's selling may very well get that talking point off the books and set the stage for a solid run to the end...
Monday's top analyst upgrades, downgrades and initiations include EMC, Herbalife, Micron Technology, Petrobras and SanDisk.
Source: via Wikimedia CommonsIt looks like Congress and the president still cannot figure out how to play well with each other, and now we have another impending government shutdown. The reality is...
August 2, 2013: U.S. equity markets opened lower this morning following a mixed report on U.S. employment. The monthly report on personal income and outlays was also a mixed bag, with core prices...
Source: Jon OggIt is Friday and the markets have another monthly employment report to absorb, but Wall Street analysts also have many research calls that have been made. 24/7 Wall St. reviews many...
Investors couldn’t have missed seeing the recent waves of new corporate share buyback plans. What they may have not noticed as clearly is the increasing trend in “legal insider trading” —...
These are some of this morning’s top pre-market analyst upgrades and positive research calls from Wall Street this Thursday morning with over two hours until the market opens: Axsys...